# FDA Inspection 572761 - Vitalant - March 17, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/vitalant/ff434017-002b-4a52-ab22-4e1b3cbcdf0d/
Source feed: FDA_Inspections

> FDA Inspection 572761 for Vitalant on March 17, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 572761
- Company Name: Vitalant
- Inspection Date: 2009-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1015492 - 2017-05-16](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/d3d6357c-ae44-44fc-b142-b4b0d40dde7c/)
- [FDA Inspection 905410 - 2014-11-07](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/91301606-3321-4f8f-875c-b51e5c751d9a/)
- [FDA Inspection 809555 - 2012-11-29](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/a5765cee-8ca2-4ad1-9d2a-5d2bda601868/)
- [FDA Inspection 707742 - 2011-01-18](https://www.globalkeysolutions.net/api/records/fda_inspections/vitalant/fc5cb361-ed5e-4535-a9c9-2bd90bac85e1/)

Company: https://www.globalkeysolutions.net/companies/vitalant/6cecd6c7-9ce5-41d3-bb16-efe4b2aba6da

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d